IRMD
Iradimed
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IRMD
- PE Ratio
The current PE ratio for Iradimed stock as of Jun 3, 2026 is 48.99. This is calculated based on the TTM EPS of $1.86 and the stock price of $91.12 per share. The PE ratio marks an increase of 5% from its last 4 quarters average of 46.5.
IRMD PE ratio history
The average historical PE ratio of Iradimed for the last ten years is 60.3. The current P/E ratio of 48.99 is 19% lower than the historical average. Looking back at the last ten years, IRMD's PE ratio peaked in the Mar 2021 quarter at 322.13, when the price was $25.77 and the EPS was $0.08. The lowest point was in the Dec 2016 quarter, when it reached 16.32 with a price of $11.1 and an EPS of $0.68.
Iradimed PE ratio by year
Maximum annual increase: 1,756.62% in 2017
Maximum annual decrease: -86.32% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 54.96 | 51.91% | $97.28 | $1.77 |
| 2024 | 36.18 | 3.67% | $55 | $1.52 |
| 2023 | 34.9 | 25.81% | $47.47 | $1.36 |
| 2022 | 27.74 | -54.38% | $28.29 | $1.02 |
| 2021 | 60.8 | -68% | $46.21 | $0.76 |
| 2020 | 190 | 590.66% | $22.8 | $0.12 |
| 2019 | 27.51 | -33.65% | $23.38 | $0.85 |
| 2018 | 41.46 | -86.32% | $24.46 | $0.59 |
| 2017 | 303 | 1,756.62% | $15.15 | $0.05 |
| 2016 | 16.32 | -60.41% | $11.1 | $0.68 |
| 2015 | 41.22 | -26.51% | $28.03 | $0.68 |
| 2014 | 56.09 | N/A | $12.9 | $0.23 |
| 2013 | N/A | N/A | N/A | $0.28 |
| 2012 | N/A | N/A | N/A | $0.14 |
Iradimed PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 51.75 | -5.84% | $96.26 | $1.86 |
| Dec 2025 | 54.96 | 28.98% | $97.28 | $1.77 |
| Sep 2025 | 42.61 | 16.17% | $71.16 | $1.67 |
| Jun 2025 | 36.68 | 9.72% | $59.79 | $1.63 |
| Mar 2025 | 33.43 | -7.6% | $52.48 | $1.57 |
| Dec 2024 | 36.18 | 6.47% | $55 | $1.52 |
| Sep 2024 | 33.98 | 14.45% | $50.29 | $1.48 |
| Jun 2024 | 29.69 | -4.16% | $43.94 | $1.48 |
| Mar 2024 | 30.98 | -11.23% | $43.99 | $1.42 |
| Dec 2023 | 34.9 | 1.45% | $47.47 | $1.36 |
| Sep 2023 | 34.4 | -16.42% | $44.37 | $1.29 |
| Jun 2023 | 41.16 | 14.02% | $47.74 | $1.16 |
| Mar 2023 | 36.1 | 30.14% | $39.35 | $1.09 |
| Dec 2022 | 27.74 | -3.11% | $28.29 | $1.02 |
| Sep 2022 | 28.63 | -16.48% | $30.06 | $1.05 |
IRMD Price vs fair value
IRMD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, IRMD's PE ratio is higher than the 3 and 5-year averages, but it is lower than its 10-year average.
PE comparison
With a price to earnings (P/E) of 48.99, IRMD ranks higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 23.02, Iradimed's price to earnings (P/E) is 113% higher.
IRMD PE vs peers
IRMD's PE ratio stands higher than its peer stocks EW and DXCM.
| Stock name | PE ratio | Market cap |
|---|---|---|
| DXCM Dexcom Inc | 30.25 | $28.01B |
| COO Cooper Companies Inc | 31.04 | $12.29B |
| EW Edwards Lifesciences Corp | 46.26 | $50.34B |
| IRMD Iradimed Corp | 50.31 | $1.2B |
Frequently asked questions
What is Iradimed's PE ratio?
IRMD stock has a price to earnings ratio of 48.99 as of Jun 3, 2026.
What is the 3-year average PE ratio for Iradimed (IRMD)?
The 3-year average price to earnings ratio for IRMD stock is 38.39.
What is the 5-year average PE ratio for Iradimed (IRMD)?
The 5-year average price to earnings ratio for IRMD stock is 42.45.
What is the highest PE ratio for IRMD?
Over the last ten years, the Mar 2021 quarter recorded the highest quarterly PE ratio at 322.13.
How does the current PE ratio for IRMD compare to its historical average?
The current PE ratio of IRMD is 19% lower than the 10-year historical average.
How is IRMD's PE ratio calculated (Iradimed PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jun 3, 2026), Iradimed's share price is $91.12. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.86. Therefore, Iradimed's PE ratio for today is 48.99. PE RATIO(48.99) = STOCK PRICE($91.12) / TTM EPS($1.86)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.